Distinct molecular pathways mediate Mycn and Myc-regulated miR-17-92 microRNA action in Feingold syndrome mouse models
Feingold syndrome is a skeletal dysplasia caused by mutations in MYCN or MIR17HG, but it is not clear if these mutations lead to pathology via a common molecular mechanism. Here, the authors show that mutations in MIR17HG lead to upregulated TGF-β signaling in limb mesenchymal cells, while mutations...
Guardado en:
Autores principales: | Fatemeh Mirzamohammadi, Anastasia Kozlova, Garyfallia Papaioannou, Elena Paltrinieri, Ugur M. Ayturk, Tatsuya Kobayashi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cce31e82791243b5bd7fb58a95b1fffa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polycomb repressive complex 2 regulates skeletal growth by suppressing Wnt and TGF-β signalling
por: Fatemeh Mirzamohammadi, et al.
Publicado: (2016) -
Regulation of B-cell development and tolerance by different members of the miR-17∼92 family microRNAs
por: Maoyi Lai, et al.
Publicado: (2016) -
An ALYREF-MYCN coactivator complex drives neuroblastoma tumorigenesis through effects on USP3 and MYCN stability
por: Zsuzsanna Nagy, et al.
Publicado: (2021) -
MicroRNA cluster miR-17-92 regulates multiple functionally related voltage-gated potassium channels in chronic neuropathic pain
por: Atsushi Sakai, et al.
Publicado: (2017) -
MYCN amplification and ATRX mutations are incompatible in neuroblastoma
por: Maged Zeineldin, et al.
Publicado: (2020)